Authors' refute careless talk about ADP receptor antagonists

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7371.1036/a (Published 02 November 2002) Cite this as: BMJ 2002;325:1036
  1. Imad W Uthman (iuthman@aub.edu.lb), associate professor,
  2. Habib A Dakik, associate professor,
  3. Ibrahim Salti, associate professor,
  4. Rachid Haidar, associate professor
  1. American University of Beirut Medical Centre, PO Box 113-6044, Beirut 1103 2090, Lebanon

    EDITOR—In January we reported the case of a patient who developed acute arthritis after taking ticlopidine.1 After reviewing the literature and discovering another two case reports of acute arthritis associated with the use of a similar drug (clopidogrel),2 we suggested that this class of ADP receptor antagonists should be considered as a potential cause of acute arthritis.

    In April a letter by Green et al implied that our report was “careless talk that may cost lives,”3 which we refute.

    Firstly, Green et …

    View Full Text

    Sign in

    Log in through your institution